Literature DB >> 23489520

Autoimmune reactivity against precursor form of desmoglein 1 in healthy Tunisians in the area of endemic pemphigus foliaceus.

Amina Toumi1, Marwah Adly Saleh, Jun Yamagami, Olfa Abida, Maryem Kallel, Abderrahmen Masmoudi, Sondes Makni, Hamida Turki, Takahisa Hachiya, Keiko Kuroda, John R Stanley, Hatem Masmoudi, Masayuki Amagai.   

Abstract

BACKGROUND: Desmoglein 1 (Dsg1), the pemphigus foliaceus (PF) antigen, is produced as a precursor (preDsg1) and is transported to the cell surface as the mature form (matDsg1). Recent studies show that B cells from North American individuals without pemphigus can potentially produce anti-preDsg1 IgG antibodies, but ELISA screening of large numbers of normal people in North America and Japan hardly ever shows circulating antibodies against preDsg1 or matDsg1. In contrast, in Tunisia, where PF is endemic, anti-Dsg1 IgGs are frequently detected in healthy individuals.
OBJECTIVE: To characterize these anti-Dsg1 antibodies from normal individuals in Tunisia.
METHODS: Sera from 16 healthy individuals and 9 PF patients in the endemic PF area in Tunisia, and sera from Japanese non-endemic PF patients were analyzed by immunoprecipitation-immunoblotting using recombinant proteins of preDsg1, matDsg1, and domain-swapped Dsg1/Dsg2 molecules.
RESULTS: Sera from normal Tunisian individuals reacted to preDsg1 alone (8/16) or more strongly to preDsg1 than to matDsg1 (7/16), while those from all Tunisian PF patients and Japanese non-endemic PF patients reacted similarly to preDsg1 and matDsg1, or preferentially to matDsg1. The epitopes recognized by anti-Dsg1 IgGs from normal Tunisian individuals were more frequently found in the C-terminal extracellular domains (EC3 to EC5), while those in Tunisian endemic PF patients were more widely distributed throughout the extracellular domains, suggesting IgGs against EC1 and EC2 developed during disease progression.
CONCLUSIONS: These findings indicate that IgG autoantibodies against Dsg1 are mostly raised against preDsg1 and/or C-terminal domains of Dsg1 in healthy Tunisians in the endemic area of PF.
Copyright © 2013 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489520      PMCID: PMC3622174          DOI: 10.1016/j.jdermsci.2013.02.002

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  31 in total

1.  The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research.

Authors:  S J Warren; M S Lin; G J Giudice; R G Hoffmann; G Hans-Filho; V Aoki; E A Rivitti; V Santos; L A Diaz
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

2.  Novel insights into cadherin processing by subtilisin-like convertases.

Authors:  Horst Posthaus; Claire M Dubois; Eliane Müller
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

3.  N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane.

Authors:  James K Wahl; Young J Kim; Janet M Cullen; Keith R Johnson; Margaret J Wheelock
Journal:  J Biol Chem       Date:  2003-02-25       Impact factor: 5.157

4.  Predominant autoantibody production by early human B cell precursors.

Authors:  Hedda Wardemann; Sergey Yurasov; Anne Schaefer; James W Young; Eric Meffre; Michel C Nussenzweig
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

5.  Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus.

Authors:  Y Futei; M Amagai; K Ishii; K Kuroda-Kinoshita; K Ohya; T Nishikawa
Journal:  J Dermatol Sci       Date:  2001-05       Impact factor: 4.563

6.  Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study.

Authors:  Giovanni Di Zenzo; Sybille Thoma-Uszynski; Valentina Calabresi; Lionel Fontao; Silke C Hofmann; Jean-Philippe Lacour; Francesco Sera; Leena Bruckner-Tuderman; Giovanna Zambruno; Luca Borradori; Michael Hertl
Journal:  J Invest Dermatol       Date:  2011-06-23       Impact factor: 8.551

7.  Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.

Authors:  M Kallel Sellami; M Ben Ayed; H Mouquet; L Drouot; M Zitouni; M Mokni; M Cerruti; H Turki; B Fezza; I Mokhtar; A Ben Osman; A Zahaf; M R Kamoun; P Joly; H Masmoudi; S Makni; F Tron; D Gilbert
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

8.  Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.

Authors:  Hidemi Anzai; Yoshiko Fujii; Koji Nishifuji; Miyo Aoki-Ota; Takayuki Ota; Masayuki Amagai; Takeji Nishikawa
Journal:  J Dermatol Sci       Date:  2004-08       Impact factor: 4.563

9.  Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome.

Authors:  Yasushi Hanakawa; Norman M Schechter; Chenyan Lin; Luis Garza; Hong Li; Takayuki Yamaguchi; Yasuyuki Fudaba; Koji Nishifuji; Motoyuki Sugai; Masayuki Amagai; John R Stanley
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

10.  The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem).

Authors:  Ning Li; Valeria Aoki; Gunter Hans-Filho; Evandro A Rivitti; Luis A Diaz
Journal:  J Exp Med       Date:  2003-05-27       Impact factor: 14.307

View more
  3 in total

1.  Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.

Authors:  Flor Evangelista; Aleeza J Roth; Phillip Prisayanh; Brenda R Temple; Ning Li; Ye Qian; Donna A Culton; Zhi Liu; Oliver J Harrison; Julia Brasch; Barry Honig; Lawrence Shapiro; Luis A Diaz
Journal:  J Autoimmun       Date:  2018-01-04       Impact factor: 7.094

Review 2.  From Insect Bites to a Skin Autoimmune Disease: A Conceivable Pathway to Endemic Pemphigus Foliaceus.

Authors:  Ning Li; Valeria Aoki; Zhi Liu; Phillip Prisayanh; Jesus G Valenzuela; Luis A Diaz
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

3.  Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.

Authors:  Marwah Adly Saleh; Ines Zaraa; Nejib Doss; Noha Adly Saleh; Dedee F Murrell
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.